Conejo Valley could be the next big biotech hotspot

Thousand Oaks’ biotech hub continues to grow and could rival the largest ones in the country in the next 10-15 years, speakers at a March 10 regional economic forecast program said. The Thousand Oaks City Council has recognized that the growth of the life sciences sector is essential to the city’s economic development, City Manager Read More →

Cottage Health translates virtual care

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s $150 million investment aims to scale, diversify middle-market business

By Mark Alfred Special to the Business Times Thousand Oaks-based Amgen, one of the largest biotechnology companies in the world, invested $150 million into Project Black: an Ariel Investments fund intended to transform middle-market companies into certified minority-owned business enterprises. The fund, managed by Ariel’s private equity subsidiary Ariel Alternatives, is based in Chicago. It Read More →
CSUCI nursing aims to challenge bias in the medical field
Research continues to show that Black mothers and babies have the worst childbirth outcomes in the United States. And while this figure only focuses on one field of medicine — obstetrics/gynecology — the nursing program at CSU Channel Islands aims to challenge implicit bias among their pre-medical students and professionals. “Our faculty are engaged in Read More →

Community Memorial rebrands to signal a new era

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sientra announces reverse stock split to boost shares

Sientra, a medical aesthetics company focused on breast augmentation, announced on Jan. 20 that its board of directors approved a 1-for-10 reverse stock split of the company’s issued and outstanding common stock. The reverse stock split was effective as of 1 p.m. on Jan. 19 while the company’s common stock began trading on the Nasdaq Read More →